$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the indications for ruxolitinib ointment?
2026-02-01 22:25:32
Check Details
Midostaurin: Innovative treatment for blood cancers
2026-02-01 22:25:32
Check Details
Is Midostaurin available globally?
2026-02-01 22:25:32
Check Details
What is the latest price of Midostaurin in 2024?
2026-02-01 22:25:32
Check Details
Overview of Tibsovo Instructions for Use
2026-02-01 22:25:32
Check Details
Applicable groups and treatment advantages of Tibsovo
2026-02-01 22:25:32
Check Details
A comprehensive guide to purchasing and using ivonib
2026-02-01 22:25:32
Check Details
Detailed explanation of crizotinib reimbursement policy and process
2026-02-01 22:25:32
Check Details
Detailed explanation of crizotinib side effects and treatment strategies
2026-02-01 22:25:32
Check Details
Detailed explanation of crizotinib medical insurance reimbursement in 2024 and economic version selection
2026-02-01 22:25:32
Check Details
Is pneumonia serious after taking Platinib?
2026-02-01 22:25:32
Check Details
What metastases will occur after platinib resistance?
2026-02-01 22:25:32
Check Details
1
2
...
980
981
982
983
984
985
986
...
10224
10225
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
2
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
3
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
4
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
5
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
6
Eltrombopag Administration Timing and Alternative Therapy Guide
7
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
8
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
9
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
10
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
11
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
12
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons